|
|
 |
|
Viewing report
|
|
|
|
U.S. Microfluidics/Lab-on-a-chip Markets
Frost & Sullivan, May 2006
This Frost & Sullivan research service entitled U.S. Microfluidics/Lab-on-a-chip Markets provides a complete market analysis and revenue forecast. In this research, Frost & Sullivans expert analysts thoroughly examine the following markets: DNA/RNA, and protein and cell-based microfluidics.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this analysis:
- DNA/RNA
- Protein
- Cell
Market Overview
Microfluidics technology has gained importance in the healthcare business with response to the immense growth in the areas of genomics, high-throughput screening of drug targets, and lead compounds. The broad spectrum of microfluidics technology essentially provides a backbone for genomics-based drug discovery. Furthermore, the technology can be applied to clinical diagnostics, proteomics, glycomics, cell manipulation, tissue engineering, structural biology, combinatorial chemistry, environmental monitoring, and drug delivery markets. The advent of miniaturization is driving the need for microfluidics technologies. The major barrier for adoption of microfluidics technologies resides in competing traditional technologies.
This research service evaluates the current state of the life science microfluidics/lab-on-a-chip markets within the United States. The research service identifies key challenges facing the industry and strategies to overcome such obstacles. In addition, market drivers, restraints, trends, market size and potential, and product analysis are provided. The revenue forecast for the microfluidics/lab-on-achip market is determined for the period from 2006 to 2012, with the base year of 2005. Related technologies, which are not included in the scope of this study, include bioMEMS, biosensors, microreactors, and microarrays.
The microfluidics/lab-on-a-chip markets are segmented by DNA/RNA, protein, cell, and all other applications that fall into the 'other' category. The DNA/RNA market segment includes genotyping, DNA/RNA electrophoresis and quantitation, gene expression profiling, DNA/RNA amplification, DNA sequencing, and DNA/RNA sample preparation. The protein market segment includes protein electrophoresis, proteomics sample preparation/ionization, protein expression profiling, protein interactions, and structural biology (protein crystallization/optimization/promotion). The cell market segment includes cell manipulation/lysis/cytometry/electrophysiology, and cell culture/microbiology.
|
|
|
|
